Breast reconstruction study tests expanders beyond approved use

NCT ID NCT07434648

Not yet recruiting Knowledge-focused Sponsor: Medical University Innsbruck Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two different tissue expanders used in breast reconstruction after mastectomy in 80 women. Some participants will also receive radiation therapy, which is not typically recommended with these devices. Researchers will evaluate aesthetic outcomes, patient satisfaction, complications, and how radiation affects the expander material and surrounding tissue.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tissue expander (Motiva Flora or SILTEX BECKER)
What this could lead to: If successful, this study could help doctors choose the best expander for breast reconstruction and understand how radiation affects the implant material and surrounding tissue.
What could go wrong: This is an early exploratory study with only 80 participants, so results may not apply to everyone. Using expanders beyond their approved duration or with radiation carries unknown risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADJUVANT RADIOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADJUVANT RADIOTHERAPY LONG-TERM OUTCOME MASTECTOMY AND BREAST RECONSTRUCTION TISSUE EXPANDER BASED BREAST RECONSTRUCTION

More trials for these conditions

Other studies related to the condition(s) this trial covers.